Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SkinHealth Systems Inc.SKIN · Entity 6863 | Director · Chief Executive Officer | September 10, 2021 | September 14, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SkinHealth Systems Inc.
Report date September 10, 2021 · Filed September 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 50,000 |
Reported balance
After 2021-09-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-09-10 · Grant · Acquired 50,000 · Balance 50,000 F1: Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2021 Filed Sep 14, 2021 23:32 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantPerformance Restricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000064 · wf-form4_163166234592777.xml · derivative · entry 1 Carnell Clinton E. · CIK 0001859734 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting. F1 · price: Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting. F1 · derivative.exercise_date: Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting. F1 · derivative.expiration_date: Represents an award of performance-based restricted stock units that may be earned over a four-year performance period based on the achievement of performance goals related to the Company's stock price and continued employment with the Company through the end of the performance period. Each performance restricted stock unit converts on a one-for-one basis to Class A Common Stock upon vesting. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 21:25 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock | 4,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000040 · wf-form4_163001310521876.xml · nonDerivative · entry 1 Carnell Clinton E. · CIK 0001859734 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,470,174 F1 · kind: The reported acquisition reflects working capital adjustment shares issued pursuant that certain Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systms LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC. F1 · price: The reported acquisition reflects working capital adjustment shares issued pursuant that certain Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systms LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:13 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock | 435,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000025 · wf-form4_162673637550104.xml · nonDerivative · entry 1 Carnell Clinton E. · CIK 0001859734 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,466,058 F1 · kind: The reported acquisition reflects earnout shares issued pursuant that certain Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systems LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC. F1 · price: The reported acquisition reflects earnout shares issued pursuant that certain Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systems LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC. Read SEC document |
| May 20, 2021 Filed May 22, 2021 00:00 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock | 2,030,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000014 · wf-form4_162164161919637.xml · nonDerivative · entry 1 Carnell Clinton E. · CIK 0001859734 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,030,371 F1 · kind: The reported acquisition is the result of distributions for no consideration made by LCP Edge Holdco LLC to certain of its unitholders, including the reporting person, in redemption of their respective interests in LCP Edge Holdco LLC. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:24 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantStock Options (right to buy) · Derivative | 3,100,000 | $0.00 Strike: $12.85 | $0.00 |
DisclosureSEC source: 0000899243-21-019002 · doc4.xml · derivative · entry 1 Carnell Clinton E. · CIK 0001859734 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100,000 Underlying: Common Stock · 3,100,000 shares Expires 2031-05-06 F1 · security: Represents a grant of stock options under The Beauty Health Company 2021 Incentive Award Plan. Subject to accelerated vesting in certain circumstances, twenty-five percent (25%) of the stock options are scheduled to vest on each of the first four anniversaries of May 6, 2021, as long as the reporting person remains in the service of The Beauty Health Company through the applicable vesting date. F1 · derivative.exercise_date: Represents a grant of stock options under The Beauty Health Company 2021 Incentive Award Plan. Subject to accelerated vesting in certain circumstances, twenty-five percent (25%) of the stock options are scheduled to vest on each of the first four anniversaries of May 6, 2021, as long as the reporting person remains in the service of The Beauty Health Company through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.